BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 15, 2010
View Archived Issues
Alnylam provides key goals for next 18 months
Read More
Pharmasset provides new data on HCV candidate PSI-7851
Read More
ERalphaS118-P a potential biomarker for breast cancer response to tamoxifen
Read More
Novo Nordisk commences phase I trial with long-acting oral GLP-1 analogue
Read More
Sciele Pharma changes company name to Shionogi Pharma
Read More
Isis adds new drug to treat hypertriglyceridemia to development pipeline
Read More
Amicus Therapeutics presents development progress with Amigal
Read More
InterMune provides update on 2010 development program for RG-7227
Read More
Sorrento enters antibody alliance for MRSA infections
Read More
Idenix reports updated information on three of its HCV programs
Read More
AnaptysBio and Roche sign agreement for development of novel antibody therapeutics
Read More
Pharmaxis acquires Topigen
Read More
Shionogi receives marketing approval for peramivir in Japan
Read More
Genaera to sell remaining proprietary assets
Read More
Spectrum completes enrollment in second phase III pivotal apaziquone trial
Read More
Eisai submits application for approval of additional indication of Tambocor in Japan
Read More
Genfit reports results from phase I safety study of GFT-505/simvastatin combination
Read More
siRNA-nanosome formulations inhibit HCV RNA replication in interferon-resistant replicon cells
Read More
Activated protein C analogues slow progression in ALS model
Read More
Top2alpha proteasomal degradation can be inhibited to enhance cancer treatment
Read More
Novel sulfonylureas in development for diabetes therapy at Concert Pharmaceuticals
Read More
Bristol-Myers Squibb presents novel hepatitis C virus inhibitors
Read More
Yakult Honsha discovers novel Plk-1 inhibitors as oncolytics
Read More
Novel peptides for the diagnosis of invasive brain cancer described by U.S. scientists
Read More
Actelion Pharmaceuticals discloses novel antibacterials
Read More